The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Regulatory News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Jun 2015 07:00

RNS Number : 9185Q
4d Pharma PLC
23 June 2015
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

4D Pharma plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Woodford Investment Management LLP ("Woodford")

4. Full name of shareholder(s)  (if different from 3.):iv

Clients of Woodford

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

17.06.15

6. Date on which issuer notified:

18.06.15

7. Threshold(s) that is/are crossed orreached: vi, vii

20%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 GB00BJL5BR07

11,946,086

11,946,086

12,239,586

12,239,586

20.2%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

12,239,586

20.2%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Woodford, as Investment Manager

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Jon Webb

15. Contact telephone number:

01865 809023

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLIFSEREIVFIE
Date   Source Headline
19th Jul 20167:00 amRNSClinical Update
10th Jun 20167:00 amRNSClinical Update
23rd May 20164:40 pmRNSSecond Price Monitoring Extn
23rd May 20164:35 pmRNSPrice Monitoring Extension
23rd May 20162:35 pmRNSResult of AGM
23rd May 20167:00 amRNSClinical Update
22nd Apr 201610:49 amRNSAnnual Report and Notice of AGM
8th Apr 20167:00 amRNSAcquisition
31st Mar 20167:00 amRNSFinal Results
29th Feb 20164:40 pmRNSSecond Price Monitoring Extn
29th Feb 20164:35 pmRNSPrice Monitoring Extension
26th Feb 20167:00 amRNSClinical Update
11th Feb 20164:40 pmRNSSecond Price Monitoring Extn
11th Feb 20164:35 pmRNSPrice Monitoring Extension
10th Feb 20167:00 amRNSAcquisition
22nd Jan 20167:00 amRNSChange of Registered Office
19th Jan 20167:00 amRNSClinical Update
4th Jan 20169:04 amRNSHolding(s) in Company
21st Dec 20153:44 pmRNSHolding(s) in Company
17th Dec 201510:21 amRNSHolding(s) in Company
17th Dec 201510:17 amRNSHolding(s) in Company
11th Dec 20152:37 pmRNSHolding(s) in Company
11th Dec 20152:37 pmRNSHolding(s) in Company
11th Dec 20152:33 pmRNSHolding(s) in Company
8th Dec 20157:00 amRNSPlacing
3rd Dec 201512:38 pmRNSHolding(s) in Company
26th Nov 20157:00 amRNSResearch Update on MicroRx Discovery Platform
11th Nov 20157:00 amRNSClinical Trial Update
13th Oct 20157:00 amRNSHolding(s) in Company
30th Sep 20159:09 amRNSHolding(s) in Company
29th Sep 20157:00 amRNSInterim results for the period ended 30 June 2015
21st Aug 20157:00 amRNSClinical Trial Update
7th Aug 20157:00 amRNSResearch Collaboration
29th Jun 201510:56 amRNSResult of AGM
23rd Jun 20157:00 amRNSHolding(s) in Company
16th Jun 20157:00 amRNSResearch Update
5th Jun 20157:00 amRNSFinal Results
20th May 20157:00 amRNSResearch Update
22nd Apr 20152:48 pmRNSHolding(s) in Company
1st Apr 201510:53 amRNSHolding(s) in Company
30th Mar 20153:47 pmRNSAcquisition of minority interests
11th Feb 20153:38 pmRNSHolding(s) in Company
11th Feb 20152:28 pmRNSHolding(s) in Company
10th Feb 20154:04 pmRNSHolding(s) in Company
9th Feb 201510:17 amRNSResult of general meeting
21st Jan 20157:00 amRNSPlacing
7th Jan 20157:00 amRNSResearch Update
5th Jan 20157:00 amRNSResearch Update
6th Nov 20149:19 amRNSHolding(s) in Company
3rd Oct 201410:53 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.